Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administered Ruxolitinib and Artemether-Lumefantrine in Healthy Adults.
Abstract
malaria. (This study has been registered at ClinicalTrials.gov under registration no. NCT04456634).
| Authors | Chughlay, M Farouk; Barnes, Karen I; El Gaaloul, Myriam; Abla, Nada; Möhrle, Jörg J; Griffin, Paul; van Giersbergen, Paul; Reuter, Stephanie E; Schultz, Hayley B; Kress, Anita; Tapley, Peter; Webster, Rebecca A; Wells, Timothy; McCarthy, James S; Barber, Bridget E; Marquart, Louise; Boyle, Michelle J; Engwerda, Christian R; Chalon, Stephan |
|---|---|
| Journal | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY |
| Pages | AAC0158421 |
| Volume | 66 |
| Date | 1/01/2021 |
| Grant ID | |
| Funding Body | |
| URL | http://www.ncbi.nlm.nih.gov/pubmed/?term=10.1128/AAC.01584-21 |